Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non–Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure-Reference-Cited by-同舟云学术

Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non–Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure

Published:2018-11 Issue:6 Volume:19 Page:e853-e859
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Barbie David A.,Spira Alexander,Kelly Karen,Humeniuk Rita,Kawashima Jun,Kong Shengchun,Koczywas Marianna

Funder

Gilead Sciences

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference14 articles.

1. KRAS mutations in non–small-cell lung cancer;Rieley;Proc Am Thorac Soc,2009

2. Targeting KRAS mutated non–small-cell lung cancer: a history of failures and a future of hope for a diverse entity;Matikas;Crit Rev Oncol Hematol,2017

3. Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit;Zhu;Cancer Discov,2014

4. CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms;Tyner;Blood,2010

5. CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients;Pardanani;Leukemia,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DeepDRA: Drug repurposing using multi-omics data integration with autoencoders;PLOS ONE;2024-07-26

2. Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation;Oncotarget;2024-01-24

3. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery;Journal of Experimental & Clinical Cancer Research;2024-01-20

4. Application of deep generative model for design of Pyrrolo[2,3-d] pyrimidine derivatives as new selective TANK binding kinase 1 (TBK1) inhibitors;European Journal of Medicinal Chemistry;2023-02

5. Janus Kinase-Signal Transducer and Activator of Transcription Inhibitors for the Treatment and Management of Cancer;Journal of Environmental Pathology, Toxicology and Oncology;2023